TPE in Heparin-Induced Thrombocytopenia (HIT) - Clinical Trial
What is the Purpose of this Study?
We are doing this study is to understand how TPE (therapeutic plasma exchange) can help to decrease blood-clotting risk in patients.
What is the Condition Being Studied?
Heparin-induced thrombocytopenia (HIT)
Who Can Participate in the Study?
Adult men and women who are:
- Receiving unfractionated heparin (UFH) or low molecular weight heparin (LMWH).
Age Group
Adults
What is Involved?
If you choose to join this study, you will:
- Participate in the study for about 30 days
- Provide blood samples throughout the study
Study Details
Full Title
Defining the Role of Therapeutic Plasma Exchange in Heparin Induced Thrombocytopenia
Principal Investigator
Hematologist
Protocol Number
IRB:
PRO00086436
Enrollment Status
Open for Enrollment